J
Juan Diego Morillas
Researcher at Hospital Clínico San Carlos
Publications - 41
Citations - 2480
Juan Diego Morillas is an academic researcher from Hospital Clínico San Carlos. The author has contributed to research in topics: Colorectal cancer & Colonoscopy. The author has an hindex of 22, co-authored 41 publications receiving 2296 citations. Previous affiliations of Juan Diego Morillas include Complutense University of Madrid.
Papers
More filters
Journal ArticleDOI
Clinical Performance of Original and Revised Bethesda Guidelines for the Identification of MSH2/MLH1 Gene Carriers in Patients with Newly Diagnosed Colorectal Cancer: Proposal of a New and Simpler Set of Recommendations
Francisco Rodríguez-Moranta,Antoni Castells,Montserrat Andreu,Virginia Piñol,Sergi Castellví-Bel,Cristina Alenda,Xavier Llor,Rosa M. Xicola,Rodrigo Jover,Artemio Payá,Xavier Bessa,Francesc Balaguer,Joaquín Cubiella,Lidia Argüello,Juan Diego Morillas,Luis Bujanda +15 more
TL;DR: Original and revised Bethesda guidelines are equivalent, highly effective criteria for the identification of MSH2/MLH1 gene mutation carriers in patients with newly diagnosed colorectal cancer.
Journal ArticleDOI
Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening
Dolores Salas,Mercedes Vanaclocha,Josefa Ibáñez,Ana Molina-Barceló,Vicente Hernández,Joaquín Cubiella,Raquel Zubizarreta,Montserrat Andreu,Cristina Hernández,Francisco Pérez-Riquelme,José Cruzado,Fernando Carballo,Luis Bujanda,Cristina Sarasqueta,Isabel Portillo,Mariola de la Vega-Prieto,Juan Diego Morillas,Vicente Valentín,Angel Lanas,Enrique Quintero,Antoni Castells +20 more
TL;DR: Women were more likely to participate in a FIT-based strategy, especially those aged 50–59 years, and the likelihood of detection of any neoplasm was higher in the colonoscopy arm for all the population groups studied, especially in women aged 50-59 years.
Journal ArticleDOI
Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins
Anna Abulí,Anna Abulí,Ceres Fernandez-Rozadilla,Virginia Alonso-Espinaco,Jenifer Muñoz,Victoria Gonzalo,Xavier Bessa,Dolors Gonzalez,Joan Clofent,Joaquín Cubiella,Juan Diego Morillas,Joaquim Rigau,Mercedes Latorre,Fernando Fernández-Bañares,Elena Peña,Sabino Riestra,Artemio Payá,Rodrigo Jover,Rosa M. Xicola,Xavier Llor,Luis G. Carvajal-Carmona,Cristina M. Villanueva,Victor Moreno,Josep M. Piqué,Angel Carracedo,Antoni Castells,Montserrat Andreu,Clara Ruiz-Ponte,Sergi Castellví-Bel +28 more
TL;DR: ARL11, ADH1C, GALNTL2 and IL6 genetic variants may have an effect on CRC risk and 18 selected variants from the mucin gene family are selected in a case-control association study from the Spanish EPICOLON consortium.
Journal ArticleDOI
Alianza para la Prevención del Cáncer de Colon en España: un compromiso cívico con la sociedad
Juan Diego Morillas,Antoni Castells,Isabel Oriol,Ana Castañeda Pastor,Pedro Pérez-Segura,José Manuel Echevarría,Begoña Caballero,Andrés González-Navarro,Fernando Bandrés,Enric Brullet,Antonio Iniesta,Fernando Carballo,Rosa Bouzas,Aurelio Ariza,Alfredo Ibisate,Pilar García-Alfonso,Beatriz Fernández Escudero,Silvia Camacho,Ana Fernández-Marcos,Teresa González,Enrique Quintero,Angel Lanas,Mercè Marzo,Juanjo Mascort,Monserrat Andréu,Laura Cerezo,Enrique Vazquez-Sequeiros,Josep M. Borràs,Dolores Salas,Nieves Ascunce,Isabel Portillo,Mayte Herráiz,María Luisa Valle,Amalia Sotoca,Santiago Nieto,Carlos Hué,Luis Paz-Ares +36 more
TL;DR: La Alianza para the Prevencion del Cancer de Colon en Espana es una entidad independiente y sin animo de lucro, creada en el ano 2008, y que integra asociaciones de pacientes, organizaciones altruistas no gubernamentales and sociedades cientificas.
Journal ArticleDOI
Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen
JI Elizalde,J M Piqué,Victor Moreno,Juan Diego Morillas,Ignasi Elizalde,Luis Bujanda,C. M. De Argila,Angel Cosme,Agustin Castiella,Emilio Ros +9 more
TL;DR: An association between Helicobacter pylori infection and heart disease has been suggested and a potential mechanism may be inflammation‐induced atherogenic changes of lipoproteins, but epidemiological studies have provided conflicting results.